Press Releases from Aleva Neurotherapeutics (4 total)
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimul …
Lausanne, Switzerland, December 16, 2019 – Aleva Neurotherapeutics, a leading developer of implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s…
Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round
- Lead investor Banexi Ventures Partners joins strong investment consortium -
Lausanne, Switzerland, April 10, 2012 – Aleva Neurotherapeutics, a company developing next-generation implants for Deep…
Aleva Neurotherapeutics Expands Board of Directors
- Entrepreneur Martin Velasco and Industry Expert Scott R. Ward Appointed as Board Members -
Lausanne, Switzerland, March 20, 2012 – Aleva Neurotherapeutics, a company developing…
Aleva Neurotherapeutics Closes EUR 9.5 Million Series A Financing Round
- Novel Products for Deep Brain Stimulation (DBS) to Be Advanced Into the Clinic -
Lausanne, Switzerland, August 25, 2011 – Aleva Neurotherapeutics, a company developing…
Go To Page:
